FICHe eHealth Accelerator Enters Final Phase with 20 Companies

FICHeThe FICHe eHealth accelerator has announced the 20 companies that will enter the third and final phase of the program. The final phase will be a 7-month mentorship period and each company will receive up to € 152.000 in working capital.

Timo Haikonen, chairman of the evaluation committee: "It has been most gratifying to monitor and witness the enthusiasm, innovation and dedication of the FICHe finalists. Every one of them deserves a credit for their hard work. May success follow them all."

Michel van Schaik, member of the evaluation committee adds: "The overall quality of all the participants was very good. Seeing all these innovations brought to the health sector in one place, proofs there is a lot of potential out there."

Paul Pelsmaeker, founder of the European FICHe accelerator: "We are all very excited about the outcome of the evaluation. All twenty selected companies have great potential in the market and that drives the FICHe team and coaches to help them grow in the next 7 months."

The companies selected for the final phase of FICHe are:

  • Px Healthcare (Netherlands), patient experience optimizing oncology outcomes;
  • Panatomy (Germany), online smart imaging database;
  • NeticTECH (Poland), medVC, remote video/audio consultation tool;
  • Medbravo (Spain), finding treatment options based on clinical trial for cancer patients;
  • Clinical Graphics (Netherlands), cloud based service for detection of osteoarthritis;
  • Andiamo (United Kingdom), 3D body scans collaboration cloud platform;
  • Psico Smart Apps (Spain), virtual environments for the treatment of anxiety disorders;
  • Scyfer (Netherlands), deep learning platform to detect degenerative brain disease in 3D-MRI;
  • Betawerk (Netherlands), IncoSense Smart, smart care service that measures incontinence;
  • Tripmedic (Malta), multi-sided platform to match-make international patients to doctors;
  • Mind Myths (Ireland); online mindfulness platform;
  • OurPath (United Kingdom), 12-week online lifestyle programme to prevent T2D;
  • Oviva (Switzerland), remote personal dietitian platform;
  • PLUX (Portugal), biofeedback modules for Ara platform;
  • Inbiolab (Netherlands). hARMONIC, miniaturized respiratory monitor based on EMG;
  • Ideable Solutions (Spain), Kwido, multi-device platform for the care of people;
  • NeuroAtHome (Spain), gamified software platform to deliver physical and cognitive therapy;
  • HealthApp (Spain), mobile application for the treatment of eating disorders;
  • Umanick (Spain), biometric platform for patient identification with HIS/EMR integration;
  • MySphera (Spain), tools to offer full transparency of healthcare processes in hospitals.

The twenty companies will be mentored and coached through an intense 7-month period led by the three ecosystems (Amsterdam, Murcia and Oulu) that are part of the project consortium.

The FICHe accelerator program will conclude with a demo day in 2016 where all companies will present to investors.

Related news articles:

About FICHe
FICHe provides companies with the overall funding of EUR 6.24 million for developing eHealth applications and creating sustainable business models. Funding will be distributed through a three-step process. In the first stage, companies will receive 15 000 euro for business model development. In the next phase, 40 out of the 80 companies will receive 50 000 euro for proof-of-concept. The third phase entering 20 out of the 40 companies will receive additionally 152 000 euro for working prototype development. At best, companies are therefore offered up to 217 000 euros funding.

FICHe is co-funded under the European Union's Programme for research, technological development and demonstration. Project partners are University of Oulu, Business Oulu, TIC BioMed, FFIS de la region de Murcia, TNO, Amsterdam Economic Board, Stichting zorgInc., Dutch eHealth Fund Management BV and Stichting Digitalezorg.nl.

About FIWARE technology
FIWARE is an innovative, open cloud-based infrastructure for cost-effective creation and delivery of Future Internet applications and services, at a scale not seen before. FIWARE API specifications are public and royalty-free, driven by the development of an open source reference implementation which accelerates the availability of commercial products and services based on FIWARE technologies.

Most Popular Now

AI Body Composition Measurements can Pre…

Adiposity - or the accumulation of excess fat in the body - is a known driver of cardiometabolic diseases such as heart disease, stroke, type 2 diabetes, and kidney disease...

AI can Strengthen Pandemic Preparedness

How to identify the next dangerous virus before it spreads among people is the central question in a new Comment in The Lancet Infectious Diseases. In it, researchers discuss how...

'Future-Guided' AI Improves Se…

In the world around us, many things exist in the context of time: a bird’s path through the sky is understood as different positions over a period of time, and...

New AI Tool Scans Social Media for Hidde…

A new artificial intelligence tool can scan social media data to discover adverse events associated with consumer health products, according to a study published September 30th in the open-access journal...

Study Finds One-Year Change on CT Scans …

Researchers at National Jewish Health have shown that subtle increases in lung scarring, detected by an artificial intelligence-based tool on CT scans taken one year apart, are associated with disease...

New AI Tools Help Scientists Track How D…

Artificial intelligence (AI) can solve problems at remarkable speed, but it’s the people developing the algorithms who are truly driving discovery. At The University of Texas at Arlington, data scientists...

Yousif's Story with Sectra and The …

Embarking on healthcare technology career after leaving his home as a refugee during his teenage years, Yousif is passionate about making a difference. He reflects on an apprenticeship in which...

AI Tool Offers Deep Insight into the Imm…

Researchers explore the human immune system by looking at the active components, namely the various genes and cells involved. But there is a broad range of these, and observations necessarily...

New Antibiotic Targets IBD - and AI Pred…

Researchers at McMaster University and the Massachusetts Institute of Technology (MIT) have made two scientific breakthroughs at once: they not only discovered a brand-new antibiotic that targets inflammatory bowel diseases...

Highland to Help Companies Seize 'N…

Health tech growth partner Highland has today revealed its new identity - reflecting a sharper focus as it helps health tech companies to find market opportunities, convince target audiences, and...